CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-495

Once the new financial results are released the numbers should look much better as they will be a cleaner representation of the company going on and it won't look so disastrous on screening metrics with the impairment which masked the fiscal improvement. Clearly needs some other catalyst to get people to bid up though and with the volatility of the market could get cheaper from here still, but its 4 years of horizontalish movement so any breakout has the potential to be big but has failed to break resistance with multiple announcements in the last year, so clearly there isn't enough FOMO